Medivolve Inc. MEDVF
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 67.89% | -109.77% | -- | 73.24% | -89.81% |
| Total Depreciation and Amortization | -67.63% | -432.68% | -- | -89.67% | 16.58% |
| Total Amortization of Deferred Charges | -- | -50.11% | -- | -- | -- |
| Total Other Non-Cash Items | -123.70% | 225.38% | -- | -86.35% | 563.84% |
| Change in Net Operating Assets | 204.64% | 113.50% | -- | 254.83% | -105.50% |
| Cash from Operations | 76.79% | 67.49% | -- | 147.69% | -126.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.64% | 94.51% | -- | 98.45% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 92.32% | 94.51% | -- | 98.54% | -6,084.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.37% | 74.07% | -- | 122.40% | -129.04% |